The Current Ratio as of June 2026 (TTM) for Marinus Pharmaceuticals, Inc. (MRNS) is 4.07

According to Marinus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.07. This represents a change of 46.79% compared to the average of 2.77 of the last 4 quarters.

Marinus Pharmaceuticals, Inc. (MRNS) Historical Current Ratio (quarterly & annually)

How has MRNS Current Ratio performed in the past?

The mean historical Current Ratio of Marinus Pharmaceuticals, Inc. over the last ten years is 9.63. The current 4.07 Current Ratio has changed 4.13% with respect to the historical average. Over the past ten years (40 quarters), MRNS's Current Ratio was at its highest in in the March 2018 quarter at 29.94. The Current Ratio was at its lowest in in the September 2024 quarter at 1.66.

Marinus Pharmaceuticals, Inc. (MRNS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Marinus Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Marinus Pharmaceuticals, Inc. (MRNS) Average Current Ratio

How has MRNS Current Ratio performed in the past?

The current Current Ratio of Marinus Pharmaceuticals, Inc. (MRNS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Marinus Pharmaceuticals, Inc. (MRNS) Current Ratio vs. Peers

How is MRNS’s Current Ratio compared to its peers?

Marinus Pharmaceuticals, Inc.’s Current Ratio is greater than Angion Biomedica Corp. (2.24), less than Allakos Inc. (14.23), greater than Lunai Bioworks Inc. (0.19), less than Serina Therapeutics, Inc. (4.18), greater than Freeline Therapeutics Holdings plc (2.18), greater than AnPac Bio-Medical Science Co., Ltd. (0.32), less than Opus Genetics, Inc. (7.13), less than LianBio (1.47K), greater than IsoPlexis Corporation (4.06), greater than HEXO Corp. (0.81),

Build a custom stock screener for Marinus Pharmaceuticals, Inc. (MRNS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marinus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Marinus Pharmaceuticals, Inc. (MRNS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Marinus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.